Tuesday, May 10, 2022 5:47:41 AM
Good Morning NSAV shareholders. Many of you are asking if our Q1 financial statements will be filed by the due date of May 16, 2022 or next Monday. As many of you are aware and as most OTC companies also do, we take the allowed OTC Markets extension, for which there is no penalty https://twitter.com/nsavtech/status/1523956331702534145?s=21&t=Sj4sEmG15_nj69KnGykiEg
However, many NSAV shareholders, especially with the global markets in turmoil, have requested that we file our Q1 financial statements by the May 16 due date. We heard you and we will file on or before this coming Monday's due date and are pleased to do so. https://twitter.com/nsavtech/status/1523957697024081920?s=21&t=Sj4sEmG15_nj69KnGykiEg
Another reason that we want to file the NSAV Q1 financial statements on or before Monday's due date, is because management is excited for all shareholders to see the progress that NSAV has made since our 2021 year end financial statements and especially compared to Q1 2020. https://twitter.com/nsavtech/status/1523958725425434625?s=21&t=Sj4sEmG15_nj69KnGykiEg
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM